Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @F1000Research
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @F1000Research
-
Aiding global health efforts against
#2019nCoV -@RobertLKruse@HopkinsMedicine recommends pursuing ACE2-Fc biologic agent. He explains the potential benefits of using this agent, providing that manufacturing soon starts on an available sequence#Outbreak https://f1000research.com/articles/9-72 pic.twitter.com/allKqbRpAN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F1000Research proslijedio/la je Tweet
Goal of global health efforts against 2019-nCoV is to effectively quarantine patients & screen individuals who may be infected to limit spread. Proposal i. Best potential treatment option in RK opinion, ii. Instructions on how to manufacture the therapy for testing in patients.pic.twitter.com/UCA88i6txM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F1000Research proslijedio/la je Tweet
My article on
#2019nCoV outbreak is now online: "Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China". Raced to write and revise in one week! Embracing#openinnovation to solve#WuhanCoronavirus crisis. https://f1000research.com/articles/9-72Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Presenting Pathfinder, an open source application for analysing spatial navigation behaviours. In this software tool article published in our
@INCForg gateway, the authors present their simple to use tool for studying navigational strategies
https://f1000research.com/articles/8-1521 pic.twitter.com/25PDFniqZG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F1000Research proslijedio/la je Tweet
The INCF channel on the
@F1000research platform provides an open publishing channel for neuroinformatics research, with immediate publication and transparent peer review. No limitation on article size, type, or perceived impact! http://f1000research.com/gateways/incf pic.twitter.com/LG88z3IO9w
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F1000Research proslijedio/la je Tweet
What types of
#BusinessModels are appropriate when it comes to#OpenData? Does a model that works for#HPC#CloudComputing apply to#bioinformatics#software? Read our latest@F1000Research position paper to find out more: https://buff.ly/38QpgjW pic.twitter.com/jj4l9u289D
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F1000Research proslijedio/la je Tweet
How can libraries and funders drive APC transparency? In our most recent webinar we were lucky enough to be joined by
@ashleydfarley from the@gatesfoundation, to answer this question and to touch on her experience of working at a major research funder
https://blog.f1000.com/2020/01/31/how-libraries-and-funders-can-drive-apc-transparency/ …pic.twitter.com/x1NfxujPIV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F1000Research proslijedio/la je Tweet
Special thanks to the
@F1000Research team for working with me to expedite publishing this past week to reach the#2019nCoV#coronavirus research community quickly, important in this outbreak scenario. https://f1000research.com/articles/9-72/v1 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A quick update – Just within 5 days of publishing, this brief report on the
#Coronavirus has been updated. This is 1 of the benefits of our#OpenResearch model, allowing you to rapidly update & improve your research. Version 2 is available now#Outbreak https://f1000research.com/articles/9-52 pic.twitter.com/2TwqaQlb3b
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F1000Research proslijedio/la je Tweet
We said
@HRBOpenRes would be a game changer for Ireland, & now take a look at this – the platform is indexed in Pubmed central! This will increase the visibility of all the platform articles indexed on#Pubmed.#OpenResearch#ILoveIrishResearch@hrbireland https://www.ncbi.nlm.nih.gov/pmc/journals/3752/ …pic.twitter.com/keSaydf2wy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Peer review may feel like it has been around forever, but do you know how it all began? For a potted history of
#PeerReview and@F1000Research's place within it, read this blog by Yousuf Al-Mousawi, Senior Editorial Assistant@F1000Research
https://blog.f1000.com/2020/01/31/a-brief-history-of-peer-review/ …pic.twitter.com/hS2SEeXeB3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Coronavirus Gateway area on
@F1000Research provides a platform for rapid dissemination of the latest research related to Coronavirus, making the information publicly available so that others can respond effectively https://f1000research.com/gateways/disease_outbreaks/coronavirus …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We will support researchers, journals & funders to ensure that all research findings & data relevant to this outbreak are shared rapidly & openly to inform the public health response & ultimately help save lives.
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The outbreak of the novel coronavirus in China represents a significant & urgent threat to global health. We are pleased to sign the joint statement– & to be working with our new partners Taylor & Francis who are now doing the same.https://twitter.com/wellcometrust/status/1223231160073015297 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Find out how patient
#data registries can help to save lives@AMRC https://amrcopenresearch.org/documents/2-10 Read the impact report highlighting the innovative ways they're used to benefit#patients.#OpenResearch#Health https://amrcopenresearch.org/ pic.twitter.com/fzZTAN6wLe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Following their analysis, researchers suggest that domain 288–330 of S1 protein from
#coronavirus represents a promising#Vaccine target. The report is published#OpenResearch to make the information publicly available & is currently awaiting#PeerReview https://f1000research.com/articles/9-52 pic.twitter.com/bIQj7WXFs2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"The authors don't give a one-size-fits-all answer, choosing quite reasonably to highlight where different tools make most sense" says Thomas Kluyver
@EuropeanXFEL in his review of this opinion article by@WrightingApril and co-authors https://f1000research.com/articles/8-1854 pic.twitter.com/8YxeBFzbWj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@AMRC charities fund over 40% of publicly funded medical research in the UK – check out how charities are making a difference https://amrcopenresearch.org/documents/2-12 After reading through the report, browse through the published research funded by AMRC member charities https://amrcopenresearch.org/ pic.twitter.com/K0ZSu4M10m
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F1000Research proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Novel
#coronavirus is highly related to#SARS & to a lesser degree related to#MERS, suggest@veleveljkovic & researchers@CReSA_r@irtacat. Their analysis using informational spectrum method is awaiting#PeerReview & available now#OpenResearch#Outbreak https://f1000research.com/articles/9-52 pic.twitter.com/4M635pU7oa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
Shared immediately with
Available online before peer review
Open access when published
Read more